Jan. 23, 2025 /Mpelembe Media/ — A Finnish research project, part of the European ITEA PROFIT initiative, explores using artificial intelligence to alleviate the workload of nurses. The project aims to develop AI tools for tasks like patient registration and information review, freeing up nurses for direct patient care. Continue reading
Jan. 14, 2025 /Mpelembe Media/ — BAIBYS™, an Israeli startup, announced its CE-marked AI-powered robotic system for autonomous sperm selection in IVF. This system uses AI and machine vision to identify and isolate optimal sperm cells, addressing the growing global issue of male infertility. Continue reading
Jan. 6, 2025 /Mpelembe Media/ — , a medical technology company, is partnering with the Mayo Clinic to pilot its Nevisense device in the US. Nevisense, an FDA-approved AI-powered tool, aids in the early detection of melanoma, the deadliest form of skin cancer. Continue reading
Jan. 3, 2025 /Mpelembe Media/ — Oncolytics Biotech Inc.’s progress in developing cutting-edge immunotherapies for cancer treatment is the article’s main subject. The piece highlights several key advancements, including clinical trial results and collaborations with other companies. Financial information regarding Oncolytics is included, along with a disclaimer about the nature of the publication. Continue reading
A live survey conducted during the “European Health Check” revealed that 77% of participants do not believe the current systemic framework applied to the generics industry is sustainable or effectively ensures the availability and accessibility of medicines for patients across the EU. This eye-opening result underscores the critical need for systemic reforms to support the generics industry, which is fundamental to delivering affordable and accessible healthcare in Europe. Continue reading
With the help of an AI tool, computed tomography (CT) scans taken originally to look for tumors or bleeding or infections, also revealed calcium buildup in arteries, a sign of worsening cardiovascular disease. Continue reading
Nearly one third of concussions in professional American football are due to impacts from the facemask, a part of the helmet that has remained mostly unchanged in the last decade. In a new study presented at the International Research Council on Biomechanics of Injury conference today, researchers used data collected from instrumented mouthpieces worn by players in the National Football League (NFL) that measured head motion and found that facemasks are the most frequent location of impact on a player’s helmet in a subset of high severity impacts. The study findings suggest that facemask enhancements could help protect players and minimize injury risk. Continue reading
MEDSIR, a leading company dedicated to advancing independent clinical research in oncology on an international level and part of Oncoclínicas & Co, the largest oncology treatment group in Latin America with significant strength in the clinical and outpatient setting, showcased its groundbreaking research at this year’s European Society for Medical Oncology (ESMO) Congress held in Barcelona. The company presented 12 new studies that address various types of cancer, marking a significant scientific milestone for MEDSIR. Continue reading
In the oncology world, there’s been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However, there’s still a lot of work to do in the war on cancer, with the 2024 World Cancer Congress in Geneva highlighting several issues, such as artificial intelligence (AI), conflict zones and crisis care taking center stage at the gathering. Continue reading
Johnson & Johnson (NYSE: JNJ) announced today that 11 oral presentations from the Company’s industry-leading solid tumor portfolio and pipeline will be featured at the 2024 World Conference on Lung Cancer (WCLC) and the European Society for Medical Oncology (ESMO) 2024 Congress. Twenty-seven studies (23 company-sponsored and four investigator-initiated), including four late-breaking abstracts, will feature new data in lung, bladder, prostate, and colorectal cancers. Continue reading